Benefits Of Standardizing Viral Vector Processes
Source: AGC Biologics

Cell and Gene therapies have experienced rapid growth and advancement in the past years as more and more products advance to clinical trials and commercialization. However, many manufacturing processes are customized and require manual processes.
Maggie Chen, Senior Director, Manufacturing & MSAT, AGC Biologics, shares insight into how the standardization process can help reduce project timelines and overall costs on the path to market.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
AGC Biologics
This website uses cookies to ensure you get the best experience on our website. Learn more